Local vs Systemic HRT for Vaginal Dryness: Which Is Right for You?

Why menopause causes vaginal dryness

Estrogen keeps the vaginal lining thick, elastic and moist, supports blood flow, and maintains the acidic pH that protects against infection. As estrogen falls, the tissue thins and dries, sex can become painful, and the urethra and bladder can become more irritable. This group of changes is called genitourinary syndrome of menopause (GSM). It affects an estimated 27% to 84% of postmenopausal women and usually progresses without treatment (NAMS 2020).

What is local (vaginal) estrogen?

Local estrogen delivers a low dose of estrogen directly to the vaginal tissue. FDA-approved options in the US include:

• Creams (estradiol or conjugated estrogens), inserted with an applicator
• Tablets or soft inserts (estradiol), placed in the vagina
• A ring (estradiol) that releases a steady low dose for about three months

Two related non-estrogen prescriptions treat the same problem: a vaginal DHEA insert (prasterone) and an oral pill, ospemifene. Some clinicians also prescribe compounded estriol cream, which is not FDA-approved; see estriol cream for vaginal atrophy.

A systematic review of 44 studies found that all commercially available vaginal estrogens improved dryness, painful sex, urinary urgency and frequency, and reduced UTIs, with similar effectiveness across products, and blood estradiol stayed within the postmenopausal range for all but high-dose cream (Rahn 2014). What local estrogen doesn't do is treat hot flashes, night sweats, sleep problems or bone loss.

What is systemic HRT?

Systemic hormone therapy raises estrogen throughout the body. It comes as pills, skin patches, gels, sprays, creams, or a higher-dose vaginal ring designed for whole-body effect. Women who still have a uterus also need a progestogen, such as progesterone, to protect the uterine lining from overgrowth.

The Menopause Society's 2022 position statement calls hormone therapy the most effective treatment for hot flashes and night sweats and for GSM, and notes it prevents bone loss and fracture (NAMS 2022). For healthy women under 60, or within 10 years of their last period, who have bothersome symptoms and no contraindications, it concludes the benefits generally outweigh the risks. Starting later carries more absolute risk of heart disease, stroke, blood clots and dementia. Learn more in our hormone replacement therapy guide.

Local vs systemic HRT: side by side

Which is right for you?

Local estrogen is usually the first choice if…

• dryness, painful sex or urinary symptoms are your only menopause symptoms
• you have reasons to avoid systemic hormones, such as a past blood clot or stroke
• you're over 60 or more than 10 years past menopause and starting treatment for the first time

The Menopause Society recommends low-dose vaginal estrogen, vaginal DHEA or ospemifene for bothersome GSM that over-the-counter products haven't relieved, in women who don't otherwise need systemic therapy (NAMS 2022).

Systemic HRT may make more sense if…

• you also have hot flashes, night sweats or menopause-related sleep problems
• you're under 60 or within about 10 years of menopause
• you don't have contraindications such as breast or endometrial cancer, prior blood clots, stroke, heart disease, active liver disease or unexplained vaginal bleeding

Many women use both

Systemic therapy doesn't always deliver enough estrogen to the vaginal tissue to fully resolve dryness and pain. Adding a low-dose vaginal product is common and is considered reasonable. Different vaginal products have similar effectiveness, so the choice often comes down to preference: cream for flexibility and vulvar application, tablets for less mess, or a ring for a three-month "set and forget" option (Lethaby 2016).

How long does each take to work?

With vaginal estrogen, many women notice less dryness and burning within a few weeks, but the lining takes about 8 to 12 weeks to rebuild fully. Creams and tablets usually start with nightly use for about two weeks, then drop to twice a week. Keep using a lubricant for sex in the meantime.

Systemic therapy often eases hot flashes within a few weeks, with fuller effect over about three months. Its effect on vaginal tissue tends to be slower and less complete, which is why some women add a local product later. With either approach, symptoms usually return if treatment stops, because the underlying estrogen loss continues.

How safe is each option?

Local estrogen

In the Women's Health Initiative Observational Study of more than 45,000 postmenopausal women not using systemic hormones, vaginal estrogen users had no higher risk of breast cancer, endometrial cancer, stroke or blood clots than non-users (Crandall 2018). Absorption is slightly higher in the first weeks, while the tissue is thin, then falls as it thickens. Long-term endometrial safety hasn't been studied in trials beyond about a year, so any bleeding after menopause should be evaluated.

Systemic HRT

Risks depend on your age, time since menopause, dose, route and type of progestogen. Estrogen through the skin appears to carry a lower risk of blood clots than oral estrogen, though this comes mainly from observational studies. The Menopause Society also recommends FDA-approved hormone products where they're suitable, because compounded hormones aren't tested for consistent strength in the same way, so it's reasonable to ask why a particular product is being recommended for you. ACOG's patient guide to the menopause years is a good plain-language overview.

If you've had breast cancer

Where Amie HRT+ fits

If you have whole-body symptoms along with dryness, systemic therapy may be worth discussing. Amie offers Amie HRT+, a single compounded cream containing estradiol and progesterone, with the strength chosen by your clinician, for hot flashes, night sweats, sleep and other menopause symptoms. It is not FDA-approved. A licensed clinician reviews your symptoms and health history, including any history of cancer, blood clots, stroke, heart or liver disease and abnormal bleeding, to decide whether it's appropriate, and whether you'd also benefit from a separate vaginal treatment. In-person care with your own gynecologist and FDA-approved products are equally valid routes.

Questions to ask your clinician

• Are my symptoms only vaginal and urinary, or do I have other menopause symptoms worth treating?
• Is anything in my history a reason to avoid systemic estrogen?
• Which vaginal product fits my preferences: cream, tablet, insert or ring?
• If I'm on systemic therapy and still dry, should I add a vaginal product?
• How will we handle any bleeding, and how often should we review my treatment?

Non-hormonal options are worth using alongside or instead of hormones. See painful sex after menopause for lubricants, moisturizers, dilators and pelvic floor therapy.